CANbridge Pharmaceuticals Inc.(HK:1228)
HK$1.70+0.08 (+4.94%)
HK:1228
CANbridge Pharmaceuticals Inc. financials statements
HK$1.70
At close:+0.08 (+4.94%)
Want to see HK:1228 full AI Analyst Report?
CANbridge Pharmaceuticals Inc. (1228) Income Statement
0 Followers
CANbridge Pharmaceuticals Inc. Income Statement
Last quarter (Q2 2026), CANbridge Pharmaceuticals Inc.'s total revenue was ¥13.97M, an increase of 25.58% from the same quarter last year. In Q2, CANbridge Pharmaceuticals Inc.'s net income was ¥-18.55M. See CANbridge Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 49.98M | ¥ 85.10M | ¥ 102.87M | ¥ 78.97M | ¥ 31.16M | |
| ¥ 36.55M | ¥ 54.30M | ¥ 64.16M | ¥ 48.89M | ¥ 18.78M | |
| ¥ 129.25M | ¥ 394.82M | ¥ 429.28M | ¥ 506.86M | ¥ 673.52M | |
| Depreciation and Amortization | ¥ 12.15M | ¥ 27.25M | ¥ 28.46M | ¥ 21.98M | ¥ 15.71M |
| ¥ -80.55M | ¥ -313.26M | ¥ -341.43M | ¥ -454.63M | ¥ -1.06B | |
| ¥ -92.70M | ¥ -340.51M | ¥ -366.55M | ¥ -457.97M | ¥ -655.15M | |
| ¥ 107.52M | ¥ -102.10M | ¥ -12.29M | ¥ -25.51M | ¥ -421.86M | |
| ¥ 14.82M | ¥ -442.62M | ¥ -378.84M | ¥ -483.48M | ¥ -1.08B | |
| ¥ 14.82M | ¥ -442.62M | ¥ -378.84M | ¥ -483.48M | ¥ -1.08B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.03 | ¥ -1.04 | ¥ -0.89 | ¥ -1.14 | ¥ -11.43 |
| Diluted EPS | ¥ 0.03 | ¥ -1.04 | ¥ -0.89 | ¥ -1.14 | ¥ -11.43 |
| Weighted Average Shares Outstanding | 456.90M | 424.83M | 424.38M | 424.21M | 94.24M |
| Weighted Average Shares Outstanding (Diluted) | 456.90M | 424.83M | 424.38M | 424.21M | 94.24M |
Currency in CNY

